CRME - Cardiome Pharma Corp.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue25,25620,91030,042
Cost of Revenue6,3106,58710,027
Gross Profit18,94614,32320,015
Operating Expenses
Research Development-3,223637
Selling General and Administrative30,51331,00433,813
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-14,551-22,081-16,585
Income from Continuing Operations
Total Other Income/Expenses Net-2,373-132-110
Earnings Before Interest and Taxes-16,924-22,213-16,695
Interest Expense2,5432,2601,483
Income Before Tax-19,467-24,473-18,178
Income Tax Expense152-1149
Minority Interest---
Net Income From Continuing Ops-21,021-24,462-18,227
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-19,619-24,462-18,227
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-19,619-24,462-18,227